Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Long-Term Safety of Tocilizumab in Patients with Rheumatoid Arthritis following a Mean Treatment Duration of 3.9 Years Haraoui, B., Sebba, A., Rubbert-Roth, A., Scali, J., Alten, R., Kremer, J., Pitts, L., Vernon, E., van Vollenhoven, R., Genovese, M. J RHEUMATOL PUBL CO. 2014: 1508
View details for Web of Science ID 000338923700166